...
首页> 外文期刊>Clinical and vaccine immunology: CVI >N-terminal prodomain of Pfs230 synthesized using a cell-free system is sufficient to induce complement-dependent malaria transmission-blocking activity
【24h】

N-terminal prodomain of Pfs230 synthesized using a cell-free system is sufficient to induce complement-dependent malaria transmission-blocking activity

机译:氨基端prodomain Pfs230综合使用无细胞系统是足够的诱导补体依赖疟疾阻断传播活动

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of a malaria transmission-blocking vaccine is to block the development of malaria parasites in the mosquito and thus prevent subsequent infection of the human host. Previous studies have demonstrated that the gametocyte/gamete surface protein Pfs230 can induce transmission-blocking immunity and have evaluated Escherichia coli-produced Pfs230 as a transmission-blocking vaccine candidate. In this study, we used the wheat germ cell-free expression system to produce N-terminal fragments of Pfs230 and evaluated the transmission-blocking activity of antisera raised against the recombinant Pfs230 protein. The rabbit antisera reacted to the surface of cultured gametocytes and gametes of the Plasmodium falciparum NF54 line, recognized the 360-kDa form of parasite-produced Pfs230 by Western blot assay, and reduced the infectivity of NF54 parasites to Anopheles stefensi mosquitoes in the presence of complement in a standard membrane feeding assay. Thus, our data demonstrate that the N-terminal pro domain of Pfs230 is sufficient to induce complement-dependent transmission-blocking activity against P. falciparum.
机译:阻断传播疟疾疫苗的目的是阻止疟疾寄生虫的发展在蚊子体内,从而防止后续人类宿主的感染。已经证明,配子体/配子表面蛋白Pfs230可以诱导阻断传播免疫和评估大肠coli-produced Pfs230作为阻断传播候选疫苗。研究中,我们使用了小麦胚芽游离表达系统生产氨基端片段Pfs230和评估阻断传播抗血清的活动提出了反对Pfs230重组蛋白质。对表面培养配子体和恶性疟原虫NF54的配子行,认识到360 kda的形式parasite-produced Pfs230通过免疫印迹分析,和减少NF54寄生虫的传染性按蚊stefensi蚊子的存在补充标准膜喂养试验。因此,我们的数据表明,氨基箴Pfs230足以诱发的领域补体依赖阻断传播活动对恶性疟原虫。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号